-
Product Insights
Bronchospasm Global Clinical Trials Review, H2, 2018
GlobalData's clinical trial report, “Bronchospasm Global Clinical Trials Review, H2, 2018" provides an overview of Bronchospasm clinical trials scenario. This report provides top line data relating to the clinical trials on Bronchospasm. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress...
-
Product Insights
Chronic Asthma Global Clinical Trials Review, H2, 2018
GlobalData's clinical trial report, “Chronic Asthma Global Clinical Trials Review, H2, 2018" provides an overview of Chronic Asthma clinical trials scenario. This report provides top line data relating to the clinical trials on Chronic Asthma. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Product Insights
Chronic Bronchitis Global Clinical Trials Review, H2, 2018
GlobalData's clinical trial report, “Chronic Bronchitis Global Clinical Trials Review, H2, 2018" provides an overview of Chronic Bronchitis clinical trials scenario. This report provides top line data relating to the clinical trials on Chronic Bronchitis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Sector Analysis
Asthma Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Asthma, a heterogeneous disease, causes variable respiratory symptoms such as wheezing, shortness of breath, chest tightness, and cough. There are millions of diagnosed prevalent cases of asthma worldwide. Although its etiology is not fully understood, certain host and environmental factors are associated with an increased risk of developing the disease. The asthma marketed and pipeline drugs market research report includes an assessment of the disease epidemiology, leading marketed products with sales forecast, pricing and reimbursement, late-to-mid-stage pipeline products with phase...
-
Sector Analysis
Hospital Acquired Pneumonia Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Pneumonia is one of the most common infectious diseases and is caused by infectious agents such as bacteria, viruses, and fungi. It is an acute respiratory infection that inflames the alveoli (air sacs) in the lungs through fluid or pus. The inflamed alveoli cause limited oxygen intake in the lungs and breathing difficulties for individuals, manifesting in symptoms of coughing, chest pain, and fever. It can be categorized into CAP, which is pneumonia developed outside of the hospital or healthcare...
-
Product Insights
Interstitial Lung Diseases (Diffuse Parenchymal Lung Disease) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
Interstitial Lung Diseases (Diffuse Parenchymal Lung Disease) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an overview of the Interstitial Lung Diseases (Diffuse Parenchymal Lung Disease) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Interstitial Lung Diseases (Diffuse Parenchymal Lung Disease), complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers the descriptive Pharmacological Action...
-
Product Insights
Lung Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
Lung Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an overview of the Lung Infections pipeline landscape. The report provides comprehensive information on the therapeutics under development for Lung Infections, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers the descriptive Pharmacological Action of the therapeutics, its complete research and development history and latest news and press releases....
-
Product Insights
Tracheobronchitis Global Clinical Trials Review, H2, 2018
GlobalData's clinical trial report, “Tracheobronchitis Global Clinical Trials Review, H2, 2018" provides an overview of Tracheobronchitis clinical trials scenario. This report provides top line data relating to the clinical trials on Tracheobronchitis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress...
-
Product Insights
Perennial Allergic Rhinitis Global Clinical Trials Review, H1, 2018
GlobalData's clinical trial report, “Perennial Allergic Rhinitis Global Clinical Trials Review, H1, 2018" provides an overview of Perennial Allergic Rhinitis clinical trials scenario. This report provides top line data relating to the clinical trials on Perennial Allergic Rhinitis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report...
-
Product Insights
Wheezing Global Clinical Trials Review, H2, 2018
GlobalData's clinical trial report, “Wheezing Global Clinical Trials Review, H2, 2018" provides an overview of Wheezing clinical trials scenario. This report provides top line data relating to the clinical trials on Wheezing. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.